- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/08 - Bridged systems
Patent holdings for IPC class C07D 498/08
Total number of patents in this class: 1125
10-year publication summary
|
59
|
67
|
82
|
62
|
60
|
75
|
82
|
96
|
91
|
32
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2720 |
37 |
| Bristol-myers Squibb Company | 4814 |
32 |
| VALO Health, Inc. | 184 |
32 |
| Amgen Inc. | 4327 |
23 |
| Merck Sharp & Dohme LLC | 3702 |
18 |
| Novartis AG | 10376 |
17 |
| Boehringer Ingelheim International GmbH | 4552 |
17 |
| Janssen Pharmaceutica N.V. | 3245 |
17 |
| Bayer Pharma AG | 1028 |
17 |
| Bayer AG | 3423 |
16 |
| Vertex Pharmaceuticals Incorporated | 1600 |
16 |
| F. Hoffmann-La Roche AG | 7832 |
15 |
| Pfizer Inc. | 3353 |
12 |
| Enanta Pharmaceuticals, Inc. | 431 |
12 |
| Epizyme, Inc. | 359 |
12 |
| Voronoi Inc. | 65 |
12 |
| Merck Patent GmbH | 5716 |
11 |
| Purdue Pharma L.P. | 495 |
10 |
| Taisho Pharmaceutical Co., Ltd. | 859 |
10 |
| Theravance Biopharma R&D IP, LLC | 428 |
10 |
| Other owners | 779 |